Zenas BioPharma, Inc.(ZBIO)
Biotechnology
Immunology & Autoimmune Biotech
| Filing Date | Insider | Type | 10b5-1 | Net Shares | Ownership change | Avg. Price | Value | Filing |
|---|---|---|---|---|---|---|---|---|
| 2026-05-18 | MOULDER LEON O JR Chief Executive Officer | Purchase | +60,000 | +162.48%96,928 | $16.88 | $1,012,800 | View SEC filing | |
| 2026-04-28 | MOULDER LEON O JR Chief Executive Officer | Purchase | +60,000 | +3.48%1,786,039 | $17.79 | $1,067,200 | View SEC filing | |
| 2026-04-02 | Lu Hongbo Director | Purchase | +3,768 | +0.89%426,736 | $18.63 | $70,198 | View SEC filing | |
| 2026-04-01 | Harwin Peter Evan Director | Purchase | +150,000 | +6.79%2,359,025 | $20.00 | $3,000,000 | View SEC filing | |
| 2026-03-31 | MOULDER LEON O JR Chief Executive Officer | Purchase | +54,000 | +3.23%1,726,039 | $18.91 | $1,021,140 | View SEC filing | |
| 2026-03-31 | Lu Hongbo Director | Purchase | +75,000 | +21.55%422,968 | $20.00 | $1,500,000 | View SEC filing | |
| 2026-02-13 | Lu Hongbo Director | Purchase | +25,985 | +8.07%347,968 | $22.50 | $584,663 | View SEC filing | |
| 2026-02-13 | Allen Patricia L Director | Purchase | +19,860 | +100.00%19,860 | $25.16 | $499,746 | View SEC filing | |
| 2026-02-03 | MOULDER LEON O JR Chief Executive Officer | Purchase | +57,000 | +15.57%423,155 | $17.96 | $1,023,720 | View SEC filing | |
| 2026-01-09 | MOULDER LEON O JR Chief Executive Officer | Purchase | +100,000 | +37.57%366,155 | $16.39 | $1,639,000 | View SEC filing | |
| 2025-10-14 | Nunn Jason Raleigh Director | Purchase | +63,158 | +5.69%1,173,395 | $19.00 | $1,200,002 | View SEC filing | |
| 2025-10-14 | George Simeon 10% Owner | Purchase | +126,315 | +4.26%3,091,290 | $19.00 | $2,399,985 | View SEC filing | |
| 2025-10-14 | ENRIGHT PATRICK G Director | Purchase | +117,255 | +6.79%1,844,659 | $19.19 | $2,250,027 | View SEC filing | |
| 2025-10-09 | MOULDER LEON O JR See Remarks | Purchase | +36,928 | +100.00%36,928 | $20.85 | $769,949 | View SEC filing | |
| 2025-10-09 | Harwin Peter Evan Director | Purchase | +316,219 | +16.71%2,209,025 | $19.00 | $6,008,161 | View SEC filing | |
| 2025-10-09 | Lu Hongbo Director | Purchase | +321,983 | +100.00%321,983 | $18.63 | $6,000,031 | View SEC filing | |
| 2025-04-28 | Xiao Ting Director | Purchase | +10,000 | +100.00%10,000 | $7.76 | $77,600 | View SEC filing | |
| 2025-02-19 | MOULDER LEON O JR Chief Executive Officer | Purchase | +25,000 | +10.37%266,155 | $6.67 | $166,750 | View SEC filing | |
| 2025-02-11 | Xiao Ting Director | Purchase | +10,000 | +27.03%47,000 | $7.76 | $77,600 | View SEC filing | |
| 2024-12-04 | MOULDER LEON O JR Chief Executive Officer | Purchase | +70,000 | +40.90%241,155 | $10.26 | $718,100 | View SEC filing | |
| 2024-11-20 | MOULDER LEON O JR Chief Executive Officer | Purchase | +10,000 | +6.21%171,155 | $14.89 | $148,925 | View SEC filing | |
| 2024-09-20 | MOULDER LEON O JR Chief Executive Officer | Purchase | +20,000 | +1.21%1,672,039 | $18.04 | $360,820 | View SEC filing | |
| 2024-09-18 | Enavate Sciences GP, LLC 10% Owner | Purchase | +882,353 | +30.65%3,761,359 | $17.00 | $15,000,001 | View SEC filing | |
| 2024-09-17 | Harwin Peter Evan Director | Purchase | +300,000 | +18.83%1,892,806 | $17.00 | $5,100,000 | View SEC filing | |
| 2024-09-17 | Lu Hongbo Director | Purchase | +58,823 | +100.00%58,823 | $17.00 | $999,991 | View SEC filing |
1-25 of 29